Thoracic Endovascular Aortic Repair for a Ruptured Mycotic Aortic Pseudoaneurysm Secondary to Esophageal Carcinoma
Author(s) -
Sean-Tee Lim,
Stephen Murphy,
Said Atyani,
Michael A. Moloney
Publication year - 2022
Publication title -
case reports in vascular medicine
Language(s) - English
Resource type - Journals
eISSN - 2090-6986
pISSN - 2090-6994
DOI - 10.1155/2022/5489653
Subject(s) - medicine , pseudoaneurysm , surgery , thoracic aorta , radiology , aorta , esophagus , esophageal squamous cell carcinoma , fistula , bleed , aortic aneurysm , complication , carcinoma
A 47-year-old female presented to the emergency department with new episodes of hematemesis. She had a background of unresectable T4b + N1 + M0 esophageal squamous cell carcinoma. Contrast CT thoracic aorta diagnosed a ruptured mycotic aortic pseudoaneurysm of the descending aorta, forming a life threating aorto-esophageal fistula secondary to neoplasm. Due to the high risk of fatal haemorrhage, she underwent successful emergency thoracic endovascular aortic repair (TEVAR). Mycotic aortic pseudoaneurysms are a rare and often fatal complication of esophageal carcinomas. They represent a small subsection of aorto-esophageal fistulas. Early diagnosis with cross sectional imaging and vascular control of the sentinel bleed is essential for survival. TEVAR may be used as a bridge to palliative treatment in the case of unresectable esophageal carcinoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom